How do drugs that inhibit HMG-CoA Reductase exert their therapeutic effect in individuals with hypercholesterolemia? Please provide a comprehensive explanation of the molecular mechanism involved.
Ahmad48Talented
Lost your password? Please enter your email address. You will receive a link and will create a new password via email.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Medications called statins, or HMG-CoA reductase inhibitors, focus on a particular biological mechanism that contributes to the creation of cholesterol. They prevent the action of the enzyme HMG-CoA reductase, which is essential for the hepatic process of early cholesterol production.
This is how it operates:
Synthesis of Cholesterol: The liver uses a number of enzymatic processes to produce cholesterol. The conversion of HMG-CoA (3-hydroxy-3-methylglutaryl-coenzyme A) to mevalonate by the enzyme HMG-CoA reductase is one of the crucial phases in this process.
Inhibition of Statins: Statins work by preventing HMG-CoA reductase from functioning. By doing this, they impede the liver’s ability to convert HMG-CoA into mevalonate, hence decreasing the rate at which cholesterol is synthesized.
Compensatory Response: The liver increases the expression of LDL receptors on the surface of hepatocytes in response to a reduction in cholesterol production brought on by statin medication. LDL cholesterol levels in the blood are lowered as a result of an increase in the absorption of circulating LDL cholesterol from the bloodstream.
Overall Effect: Statins successfully lower blood levels of LDL cholesterol, a major risk factor for cardiovascular disease, by decreasing cholesterol synthesis and enhancing LDL absorption. Statins may also have additional advantageous effects, such lowering inflammation and stabilizing artery plaque.